Back
Alterity Therapeutics Ltd. Stock Predictions
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
23
ATHE
Alterity Therapeutics Ltd.
Last Price:
$3.32
Seasonality Move:
4.13%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiAlterity Therapeutics Ltd. Stock Forecast
-
Is Alterity Therapeutics Ltd. Stock Undervalued?The current Alterity Therapeutics Ltd. [ATHE] share price is $3.43. The Score for ATHE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
-
ATHE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Alterity Therapeutics Ltd. Stock Go Up Next Year?
Data Unavailable
Alterity Therapeutics Ltd. Stock Rating
Data Unavailable
Alterity Therapeutics Ltd. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Australia
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alteritytherapeutics.com
52-Week Data
52-Week High:
7.00
52-Week Low:
1.90
Prediction Charts
Market Cap:
62.2M
Price in USD:
3.43
Volume:
5.6K
Beta:
0.88
Technical Analysis
SMA50:
4.07
SMA100:
4.55
SMA200:
4.23
52-Wk Change:
82.47%
Stock Predictions
-
Is Alterity Therapeutics Ltd. stock public?Yes, Alterity Therapeutics Ltd. is a publicly traded company.
-
What is the Alterity Therapeutics Ltd. stock quote today?The Alterity Therapeutics Ltd. stock price is 3.43 USD today.
-
How to buy Alterity Therapeutics Ltd. stock online?You can buy Alterity Therapeutics Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 3.75 | 3.84 | 3.89 | 3.75 |
| Nov-17 | 3.79 | 3.79 | 3.86 | 3.67 |
| Nov-18 | 3.55 | 3.60 | 3.70 | 3.52 |
| Nov-19 | 3.65 | 3.63 | 3.78 | 3.60 |
| Nov-20 | 3.51 | 3.52 | 3.75 | 3.47 |
| Nov-21 | 3.49 | 3.51 | 3.61 | 3.49 |
| Nov-24 | 3.53 | 3.55 | 3.61 | 3.52 |
| Nov-25 | 3.66 | 3.51 | 3.66 | 3.47 |
| Nov-26 | 3.48 | 3.78 | 3.78 | 3.48 |
| Nov-28 | 3.78 | 3.60 | 3.78 | 3.57 |
| Dec-1 | 3.58 | 3.27 | 3.58 | 3.25 |
| Dec-2 | 3.25 | 3.34 | 3.46 | 3.25 |
| Dec-3 | 3.64 | 3.48 | 3.64 | 3.47 |
| Dec-4 | 3.45 | 3.43 | 3.47 | 3.31 |
Alterity Therapeutics Ltd. Earnings
Data Unavailable
Alterity Therapeutics Ltd. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.82 per share, and a decrease next year of $0.01 per share.
* Alterity Therapeutics Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.